Post-earnings recap
Reported
Wed, Aug 6, 2025
EPS actual
$-1.22
EPS est.
$-1.12
EPS surprise
-8.64%
1-day move
-2.16%
Vaxcyte's earnings report indicates a challenging quarter, particularly with the EPS miss. The stock reacted negatively, dropping 2.16%, likely due to investor concerns about profitability. Without revenue figures or updated guidance, uncertainty remains about the company's financial trajectory.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-1.22 | N/A | -8.64% |
| Revenue | N/A | N/A | N/A |
Management expressed a cautious optimism about future projects. They emphasized the importance of their ongoing research and development efforts.
Management highlighted ongoing efforts in product development.
They acknowledged challenges but remain focused on long-term goals.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—